Further evidence to support the individualised treatment of gonorrhoea with ciprofloxacin

GRAND study investigators

Research output: Contribution to journalLetterpeer-review

19 Citations (Scopus)
Original languageEnglish
Pages (from-to)1005-1006
Number of pages2
JournalThe Lancet Infectious Diseases
Volume16
Issue number9
DOIs
Publication statusPublished - 2016
Externally publishedYes

Bibliographical note

Funding Information:
We declare no competing interests. This Correspondence was funded by the National Health and Medical Research Council (NHMRC; APP1025517). David Whiley, Rebecca Guy, and Basil Donovan are the recipients of NHMRC Fellowships. This study was done as part of the Gonorrhoea Resistance Assessment by Nucleic Acid Detection study and the reference work of the National Neisseria Network (NNN), Australia, which is funded by the Australian Government Department of Health and Ageing. We thank Athena Limnios, Rodney Enriquez, Tiffany Hogan, and Ratan Kundu of South Eastern Area Laboratory Services, Prince of Wales Hospital, New South Wales; and all members of the NNN for their assistance with this study.

Cite this